eNews
Home page > Comments


Comments

FDA OKs Onyx's Kyprolis for multiple myeloma

21.07.2012. | WASHINGTON (Reuters) - U.S. drug regulators approved Onyx Pharmaceuticals Inc's Kyprolis for people with a type of blood cancer that has failed to respond to other medicines....


Оставите Ваш коментр
*Име:

Е-пошта:


*Ваш коментар:
:) :D ;) B-) :P :-o :( x-(

*Сигурносни број: